RPS18_6_767: A Potential Drug Target and Biomarker (G645958)

Target Name: RPS18P9

NCBI ID: G645958

RPS18P9

Other Name(s): RPS18_6_767 | Ribosomal protein S18 pseudogene 9 | ribosomal protein S18 pseudogene 9

RPS18_6_767: A Potential Drug Target and Biomarker

The protein RPS18_6_767 is a member of the RPS18 gene family, which is involved in various cellular processes such as cell signaling, DNA replication, and repair. RPS18_6_767 is a 767 amino acid protein that is expressed in various tissues and cells of the body. Its function and specificity are not yet fully understood, but it is potential drug target or biomarker.

Drug Target Potential

RPS18_6_767 can be a drug target due to its unique structure and various cellular processes. Its amino acid sequence suggests that it may interact with various signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in various cellular processes, including cell survival, angiogenesis, and inflammation. Therefore, small molecules that can inhibit this pathway may be effective in targeting RPS18_6_767 and its function.

Biomarker Potential

RPS18_6_767 can also be used as a biomarker for various diseases. For example, its expression has been detected in various cancer types, including breast, ovarian, and colorectal cancer. Therefore, using RPS18_6_767 as a biomarker for cancer could be an effective way to diagnose and monitor disease progression. Additionally, its expression has also been detected in various autoimmune diseases, such as rheumatoid arthritis and psoriasis. Therefore, using RPS18_6_767 as a biomarker for autoimmune diseases could be an effective way to diagnose and monitor disease progression.

Conclusion

In conclusion, RPS18_6_767 is a protein that can be potential drug target or biomarker. Its unique structure and various cellular processes make it an attractive target for small molecules that can inhibit the PI3K/Akt signaling pathway. Additionally, its expression has been detected in various diseases, making it an potential biomarker for disease diagnosis and monitoring. Further research is needed to fully understand its function and potential as a drug target or biomarker.

Protein Name: Ribosomal Protein S18 Pseudogene 9

The "RPS18P9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS18P9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets